Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.Unknown journal · 2026-05-25Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-01-26Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-06Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigmUniversität Zürich, ZORA · 2025-11-04Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-17595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-25The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Unknown journal · 2024-04-22Fallbeispiele zur Therapie der rezidivierenden Depression mit PsilocybinNervenheilkunde · 2024-03-31Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of PsilocybinBiological Psychiatry · 2024-01-04Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2023-12-31Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesScientific Reports · 2023-10-13Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.Unknown journal · 2023-01-29Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Neural mechanisms of psychedelic visual imagerymedRxiv · 2022-09-08Effective connectivity of emotion and cognition under psilocybinmedRxiv · 2022-09-08Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2021-12-31Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorderNeuroscience Applied · 2021-12-31Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral Cortex · 2021-10-31P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin ExperienceBiomedicines · 2020-02-17Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreatScientific Reports · 2019-10-23Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-08-31Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effectsNeuroImage · 2019-04-05Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot studyZurich Open Repository and Archive (University of Zurich) · 2018-12-31Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.Unknown journal · 2017-12-31Phenomenology, Structure, and Dynamic of Psychedelic States.Current topics in behavioral neurosciences · 2017-12-31LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteersEuropean Neuropsychopharmacology · 2015-08-31The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.Journal of Neuroscience · 2013-05-31Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2012-12-31The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological Psychiatry · 2012-05-09Prediction of psilocybin response in healthy volunteers.PLoS ONE · 2012-02-16Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology · 2011-09-27The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.Journal of Psychopharmacology · 2010-09-19Psychometric evaluation of the altered states of consciousness rating scale (OAV).PLoS ONE · 2010-08-30The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.Unknown journal · 2010-08-17Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-18Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-16GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.Unknown journal · 2008-12-23Serotonin research: contributions to understanding psychoses.Unknown journal · 2008-08-31Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humansInternational Journal of Psychophysiology · 2008-07-16Effects of varied doses of psilocybin on time interval reproduction in human subjects.Neuroscience Letters · 2008-02-08Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-09-13The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology · 2007-02-13Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of Cognitive Neuroscience · 2005-09-30Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Unknown journal · 2005-05-31Psilocybin impairs high-level but not low-level motion perception.Unknown journal · 2004-07-31The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.Unknown journal · 2003-11-12P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-09-30[Hallucinogens, amphetamines and entactogens].Unknown journal · 2003-05-31A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2002-12-31Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Unknown journal · 2002-12-31Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.Unknown journal · 2002-08-31Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.Unknown journal · 2002-02-28Brain mechanisms of hallucinogens and entactogens.Unknown journal · 2001-11-30A systems model of altered consciousness: integrating natural and drug-induced psychoses.Unknown journal · 2001-10-315-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.Unknown journal · 1999-04-30Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.Unknown journal · 1998-11-30Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.Unknown journal · 1998-06-3011C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formationJournal of Labelled Compounds and Radiopharmaceuticals · 1998-06-30Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.Unknown journal · 1997-05-31Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.Unknown journal · 1997-04-30